---
title: "CRISPR Therap (CRSP.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRSP.US/norm.md"
symbol: "CRSP.US"
name: "CRISPR Therap"
parent: "https://longbridge.com/en/quote/CRSP.US.md"
datetime: "2026-05-20T23:46:44.840Z"
locales:
  - [en](https://longbridge.com/en/quote/CRSP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRSP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRSP.US/norm.md)
---

# CRISPR Therap (CRSP.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.28 | -1.37 | -1.17 | -2.40 | -1.58 |
| ROE | -26.32% | -27.23% | -23.48% | -47.13% | -28.93% |
| Revenue | 1.46M | 864000.00 | 889000.00 | 892000.00 | 865000.00 |
| Net income | -122.93M | -130.61M | -106.44M | -208.55M | -136.00M |
| Operating income | -130.25M | -154.76M | -132.06M | -133.07M | -148.42M |
| Gross margin | -7754.80% | -15782.99% | -12950.28% | -12797.65% | -14928.09% |
| Net margin | -8431.48% | -15117.25% | -11973.12% | -23379.93% | -15722.08% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 2.73B | 2.27B | 2.25B | 2.03B | 2.17B |
| Leverage | 1.50 | 1.18 | 1.17 | 1.19 | 1.18 |
| BVPS | 18.83 | 20.04 | 20.41 | 19.36 | 21.18 |
| Turnover | 0.0017 | 0.0016 | 0.0170 | 0.0174 | 0.0164 |
| Cash & STI | 2.44B | 1.98B | 1.92B | 1.72B | 1.86B |
| Inv & Rec | - | - | - | - | - |
| LT assets | 240.85M | 247.57M | 255.49M | 262.57M | 269.70M |
| Net debt | -1.65B | -1.77B | -1.73B | -1.51B | -1.64B |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -108.90M | -92.55M | -84.63M | -113.88M | -53.95M |
| Investing CF | -410.74M | 37.20M | -119.23M | 69.98M | -19.75M |
| Financing CF | 591.91M | 116.41M | 296.77M | 2.26M | 10.59M |
| Free CF | -70.87M | -40.13M | -48.16M | -101.74M | -15.60M |
| OCF coverage | -21606.55% | -17901.93% | -114370.27% | -97333.33% | -26187.86% |
| Repaid & issued | 600.00M | - | - | - | - |
| CapEx | -504000.00 | -517000.00 | -74000.00 | -117000.00 | -206000.00 |